📰 Abt News
Page 188 - Abt News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Abt. Real-time updates on events, politics, business and more.
April 1, 2023
UBS Group initiated coverage on shares of Abbott Laboratories (NYSE:ABT – Get Rating) in a research note issued to investors on Tuesday, The Fly reports. The brokerage issued a buy rating and a $117.00 target price on the healthcare product maker’s stock. Several other equities analysts have also recently commented on ABT. StockNews.com assumed coverage […]
April 1, 2023
Harbor Investment Advisory LLC grew its position in Abbott Laboratories (NYSE:ABT – Get Rating) by 2.5% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 29,109 shares of the healthcare product maker’s stock after purchasing an additional 721 shares during the period. […]
April 1, 2023
Eudaimonia Partners LLC trimmed its holdings in shares of Abbott Laboratories (NYSE:ABT – Get Rating) by 22.6% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 8,443 shares of the healthcare product maker’s stock after selling 2,469 shares during the period. Eudaimonia Partners […]
March 31, 2023
Sargent Bickham Lagudis LLC lessened its position in shares of Abbott Laboratories (NYSE:ABT – Get Rating) by 3.5% during the 4th quarter, Holdings Channel reports. The firm owned 52,584 shares of the healthcare product maker’s stock after selling 1,909 shares during the quarter. Sargent Bickham Lagudis LLC’s holdings in Abbott Laboratories were worth $5,773,000 as […]
March 31, 2023
Measured Wealth Private Client Group LLC boosted its stake in Abbott Laboratories (NYSE:ABT – Get Rating) by 4.3% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 5,959 shares of the healthcare product maker’s stock after acquiring an additional 243 shares […]
March 31, 2023
Community Bank of Raymore purchased a new stake in shares of Abbott Laboratories (NYSE:ABT – Get Rating) during the 4th quarter, HoldingsChannel reports. The firm purchased 3,225 shares of the healthcare product maker’s stock, valued at approximately $354,000. Other large investors have also added to or reduced their stakes in the company. JDM Financial Group […]
March 31, 2023
Mechanics Bank Trust Department raised its stake in Abbott Laboratories (NYSE:ABT – Get Rating) by 0.1% in the fourth quarter, HoldingsChannel.com reports. The fund owned 103,572 shares of the healthcare product maker’s stock after buying an additional 110 shares during the quarter. Abbott Laboratories accounts for 2.0% of Mechanics Bank Trust Department’s portfolio, making the […]
March 31, 2023
Geneva Partners LLC cut its holdings in Abbott Laboratories (NYSE:ABT – Get Rating) by 15.0% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 14,131 shares of the healthcare product maker’s stock after selling 2,499 shares during the period. Abbott Laboratories comprises about […]
March 31, 2023
Paces Ferry Wealth Advisors LLC lowered its stake in Abbott Laboratories (NYSE:ABT – Get Rating) by 3.3% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 3,590 shares of the healthcare product maker’s stock after selling 124 shares during the period. Paces Ferry Wealth […]
March 31, 2023
Red Door Wealth Management LLC raised its holdings in shares of Abbott Laboratories (NYSE:ABT – Get Rating) by 11.8% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 3,937 shares of the healthcare product maker’s stock after purchasing an additional […]